Low/Intermediate PCa Video Chat, April 21, 2025

by | Apr 22, 2025 | Active Surveillance PCa, Cancer Resources, Low/Intermediate Prostate Cancer, Prostate Cancer, Recorded Groups

Low/Intermediate PCa

Low/Intermediate PCa Video Chat, April 21, 2025

Low/Intermediate PCa Video Chat, April 21, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Sexuality after treatment — what are the psychological ramifications? (bj)

Topics Discussed
Active Surveillance started in 2011 and considering multiple focal treatment options (HIFU, TULSA, etc.) — be wary of focal treatments because they have higher risk of recurrence; Prostatectomy carries a higher risk of Erectile Dysfunction (ED) and Urinary Incontinence (UI); transition from Active Surveillance usually occurs because underlying cancer gets worse or patient grows tired of Active Surveillance; sexuality after treatment — what are the psychological ramifications; Prostate Cancer Research Institute (PRCI) — https:/pcri.org; Artera AI for Prostate Cancer — https://artera.ai/for-patients; For SBRT, what are the side effects and what is a PSA rise; Active Surveillance provides an opportunity for doctor shopping; choosing a doctor depends on your preference — in person or telemedicine; our brains our wonderful, but can cause unecessary anxiety or stress; PROSTOX radiation toxicity test — https://miradx.com/prostox/; CyberKnife — https://cyberknife.com/.

Chat Log

AnCan  – rick
Here’s the HIFU study we were speaking about   https://www.sciencedirect.com/science/article/abs/pii/S1078143924009487

Stuart
My mistake, there were 2 studies, the other one was in France and that is the one with the comparison.  https://pubmed.ncbi.nlm.nih.gov/39632125/

Boykin Jordan
Prostate Cancer Research Institute: https://pcri.org/

Boykin Jordan
Artera AI for Prostate Cancer https://artera.ai/for-patients

Robert Boghosian
Thank you all.  Have a good evening.

AnCan  – rick
https://www.vumc.org/urology/person/daniel-barocas-md-mph-facs   Daniel Barocas

AnCan  – rick

Study shows active surveillance preserves quality of life for prostate cancer patients

AnCan  – rick
Prostox … https://miradx.com/prostox

Hector
I don’t see Proton Therapy included in the comparison

Hector
I saw that study

Boykin Jordan
CyberKnife https://cyberknife.com/

Hector
So what was your best recommendation for radiation therapy in Florida?

Hector
Ellis does not seem to have the latest machine. Will keep an eye on Johnstone. Please let me know if you find more about the MRIdian. Thanks.